shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > Sports News > Other Sports News > Article > My dope hearing panel was not neutral Maria Sharapova

My dope hearing panel was not neutral: Maria Sharapova

Updated on: 06 October,2016 08:27 AM IST  | 
PA Sport |

Maria Sharapova claims the International Tennis Federation hearing into her doping violation was "not neutral" and she is "starting to think" the sports governing body tried to make an example of her

My dope hearing panel was not neutral: Maria Sharapova

Maria Sharapova

Maria Sharapova
Maria Sharapova


Lausanne: Maria Sharapova claims the International Tennis Federation hearing into her doping violation was "not neutral" and she is "starting to think" the sports governing body tried to make an example of her.


The 29-year-old former Wimbledon champion and World No.1 tested positive for the heart-boosting drug meldonium in January and was then sanctioned by the ITF in June.


But on Tuesday, the Court of Arbitration for Sport announced a reduction in the five-time Grand Slam winner's two-year doping ban to just 15 months.

In her first television interview since the CAS ruling, Sharapova was again critical of the ITF.

"I got a 24-month suspension, but they (ITF) wanted four years for me," Sharapova told American broadcaster PBS. I went through the ITF hearing, which was in front of an arbitration (panel), which was chosen by the ITF.

"I am at a hearing (in London) knowing the people I am speaking to were chosen by the people that I am actually in a fight with. They call that neutral? That is not neutral. CAS is neutral and this is what CAS has awarded to me."

Asked by interviewer Charlie Rose if she thought the ITF were trying to make an example of her, Sharapova replied: "I never wanted to believe that, but I am starting to think that."

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK